Greywolf Therapeutics Alternatives & Competitors
12 companies similar to Greywolf Therapeutics — We are advancing novel antigen modulation technology that controls T cells to gu...
Companies similar to Greywolf Therapeutics
Immunaeon
Connecting Today's Science to Tomorrow's Cures
Tmunity Therapeutics
Pioneering the future of immunotherapy through innovative T cell engineering to tackle a d...
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
Rival Readout
Competing with Greywolf Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
MacroGenics, Inc.
Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious disea...
Celularity Inc.
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...
AnaptysBio
Transforming patient health by delivering innovative immunology therapeutics.
HiFiBiO Therapeutics
HiFiBiO Therapeutics is a clinical stage biotherapeutics company mobilizing the human immu...
Gritstone bio
A lean biotech company aiming to develop revolutionary immune-based treatment for various...
Immunex
Pioneering therapeutic advancements for cancer, infectious diseases, and autoimmune disord...
About Greywolf Therapeutics
Greywolf Therapeutics is a biotechnology startup based in the United Kingdom, founded in 2017. The company is focused on solving immune dysfunction by advancing novel antigen modulation technology that guides the immune system. Their approach addresses the challenge of T cells not being able to recognize or target cell...
Development of antigen modulation technology for therapeutic treatments in oncology, autoimmunity, and virology
Patients with cancers, autoimmune disorders, and infectious diseases
Biotherapeutics, Immunotherapy, Cancer Treatment, Autoimmune Disorders, Infectious Diseases, T Cell Activation, Antigen Modulation, Clinical Development, Immunology, Therapeutic Innovations
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Greywolf Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Greywolf Therapeutics on 25 Feb 2025. The 12 companies listed here were last checked between 21 Jun 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.